AI-powered intelligence on FDA inspections and investigators.

FDA Intel is the leading provider of AI-powered insights into FDA inspections and investigator intelligence, for drug developers and the stakeholders around them.

Our mission

Help the teams who answer to FDA see what FDA sees, early enough to act: before an inspection, a supplier decision or a deal.

What we built

Three layers, each feeding the next.

  1. 1The libraryOne of the largest libraries of FDA inspection documents anywhere: Form 483s, inspection reports, warning letters, close-outs and responses.
  2. 2Structured dataEvery document parsed and extracted, then organized by site, investigator, regulation, observation topic, product sector and classification.
  3. 3AI-native workflowsProprietary workflows that connect each site's history and turn it into answers, profiles and reports.

What we deliver

Used for inspection readiness, due diligence, supplier vetting and competitive intelligence.

Built for the people who answer to FDA.

  • Drug and biologics developers (quality, regulatory and manufacturing)
  • Medical device makers
  • CDMOs and CMOs
  • Supplier-quality teams
  • Consultants
  • Investors and analysts (due diligence)
  • Law firms

See how each team uses it

How we work

Get in touch

Questions about intelligence, a report, an order or your team's needs? Write to info@fdaintel.ai or use the contact page.

FDA Intel is a product by Cortex Group.

See what FDA found at a site you care about. Your first Form 483 or letter is on us.